# -------------------------------------------- # CITATION file created with {cffr} R package # See also: https://docs.ropensci.org/cffr/ # -------------------------------------------- cff-version: 1.2.0 message: 'To cite package "phase12designs" in publications use:' type: software license: MIT title: 'phase12designs: Comprehensive Tools for Running Model-Assisted Phase I/II Trial Simulations' version: 0.3.1 doi: 10.32614/CRAN.package.phase12designs abstract: 'Provides a comprehensive set of tools to simulate, evaluate, and compare model-assisted designs for early-phase (Phase I/II) clinical trials, including: - BOIN12 (Bayesian optimal interval phase 1/11 trial design; Lin et al. (2020) ), - BOIN-ET (Takeda, K., Taguri, M., & Morita, S. (2018) ), - EffTox (Thall, P. F., & Cook, J. D. (2004) ), - Ji3+3 (Joint i3+3 design; Lin, X., & Ji, Y. (2020) ), - PRINTE (probability intervals of toxicity and efficacy design; Lin, X., & Ji, Y. (2021) ), - STEIN (simple toxicity and efficacy interval design; Lin, R., & Yin, G. (2017) ), - TEPI (toxicity and efficacy probability interval design; Li, D. H., Whitmore, J. B., Guo, W., & Ji, Y. (2017) ), - uTPI (utility-based toxicity Probability interval design; Shi, H., Lin, R., & Lin, X. (2024) ). Includes flexible simulation parameters that allow researchers to efficiently compute operating characteristics under various fixed and random trial scenarios and export the results.' authors: - family-names: Cao given-names: Angela email: cao.t.angela@gmail.com repository: https://angela-cao.r-universe.dev commit: 5a5f52455362b9a5ab63c728922aea43660d39f8 date-released: '2025-09-02' contact: - family-names: Cao given-names: Angela email: cao.t.angela@gmail.com